A novel approach in vaccine research offers hope for overcoming challenges in developing an effective Hepatitis C vaccine, targeting viral diversity...

Around 58 million people worldwide are chronically infected with HCV, leading to approximately 290,000 deaths each year from complications like...

Researchers at the City of Hope, one of the largest and most advanced cancer research and treatment centers in the U.S., with its National Medical...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living...

Filgotinib, a JAK1 preferential inhibitor, shows promise as an effective and well-tolerated maintenance therapy for Crohn's disease, achieving...

Scientists have developed CCI-38, a compound that targets YTHDF2 to improve CAR T cell therapy and overcome immune evasion in cancer.

The most effective way to prove a new idea is to start small, test, learn, and test again. A team of researchers developing an atmospheric probe at...

ACIAR’s research-for-development agenda fosters partnerships between Australian researchers and those in developing countries.

PAUL SARRAN THE PEOPLE’S National Movement (PNM), a cornerstone of TT’s political fabric, faces a defining moment as the country approaches the...

Officials in Russia this week claimed to have developed a mRNA-based vaccine to treat cancer, which will be available for free to patients beginning...